Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[GeneChip analysis for osteoimmunology].

Hiroshi Takayanagi1

  • 1Department of Cell Signaling, Graduate School, Center of Excellence Program, Tokyo Medical and Dental University.

Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|May 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma development.

Nature communications·2026
Same author

Self-reinforcing IL-1β signaling accelerates the development and recurrence of TCF3::HLF-positive B-ALL.

Blood·2026
Same author

Activin A secretion by muscle-repairing macrophages induces heterotopic ossification in mice.

The Journal of clinical investigation·2026
Same author

Practice-Based Research Network Activities and Future Nationwide Plans in Japan.

Journal of general and family medicine·2026
Same author

Stromal Defense Against Cancer: An Unprecedented Mechanism Limiting Cancer Invasion Into the Bone.

Cancer science·2025
Same author

Bone Voyage: OPN's Path from Skeleton to Systemic Immunosuppression.

Cancer research·2025
Same journal

[A case of mixed connective tissue disease positive for proteinase 3 antineutrophil cytoplasmic antibody in a patient with slowly progressive type 1 diabetes mellitus and chronic thyroiditis].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology·2018
Same journal

[A case of axial spondyloarthritis acute onset as opportunity tonsil foci infection].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology·2018
Same journal

[Transient detection of lupus anticoagulant in acute phase of Kawasaki disease].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology·2018
Same journal

[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology·2018
Same journal

[Autoimmune diseases and ubiquitin system].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology·2018
Same journal

[The scoring system for the risk-stratification in patients with the antiphospholipid syndrome].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology·2018
See all related articles

Osteoimmunology research reveals nuclear factor of activated T cells c1 (NFATc1) as a key regulator of osteoclastogenesis. GeneChip analysis identified NFATc1 as a master transcription factor linking immune activation to bone remodeling.

Area of Science:

  • Osteoimmunology
  • Molecular Biology
  • Immunology

Context:

  • Bone destruction is linked to immune system overactivation in diseases like rheumatoid arthritis.
  • Mice with altered immunomodulatory molecules show unexpected bone phenotypes.
  • Osteoclasts, derived from monocytes/macrophages, are crucial for bone matrix degradation.

Purpose:

  • To identify key molecular players in osteoclastogenesis using genomewide screening.
  • To analyze the role of costimulatory signals in RANKL-mediated osteoclast formation.
  • To investigate the target genes of antirheumatic drugs within the osteoimmunological context.

Summary:

  • Genomewide screening using GeneChip identified nuclear factor of activated T cells c1 (NFATc1) as the master transcription factor for osteoclastogenesis.

Related Experiment Videos

  • Receptor activator of NF-kappaB ligand (RANKL) is a critical cytokine linking the immune system and bone metabolism.
  • GeneChip analysis was applied to study RANKL-inducible genes and antirheumatic drug targets.

    • Impact:

    • Provides a deeper understanding of the molecular mechanisms underlying bone diseases associated with immune dysregulation.
    • Identifies NFATc1 as a pivotal factor in osteoclast differentiation, offering potential therapeutic targets.
    • Highlights the utility of GeneChip technology in dissecting complex osteoimmunological pathways.